Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Demographic and clinical data, lupus activity (SLEDAI) and individual therapy of the patients at the time of analysis

From: Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation

Patient ID Sex Age, y B cells/μL blood anti-dsDNA IgG, U/mL SLEDAI Treatment Prednisolone dose, mg/d
SLE1 F 61 187 0 7 Pred 5.0
SLE2 F 31 320 0 5 Pred, MTX 5.0
SLE3 F 30 159 0 4 Pred, MMF 5.0
SLE4 F 25 132 45 8 Pred, Aza, HCQ 5.0
SLE5 F 36 216 38 8 Pred, Aza 7.5
SLE6 F 39 538 50 6 Pred, MMF 5.0
SLE7 F 22 164 0 4 Pred 5.0
SLE8 F 44 108 0 5 HCQ 0
SLE9 F 48 67 75 8 Pred, MMF 5.0
SLE10 M 20 89 50 10 Pred, Aza 5.0
SLE11 F 30 305 45 6 Pred 5.0
SLE12 F 33 468 0 5 Pred 8.0
SLE13 F 23 785 125 14 Pred, HCQ 100.0
SLE14 F 33 110 18 4 Pred, HCQ 5.0
SLE15 F 32 75 60 12 Pred, MMF 8.0
SLE16 F 37 ND 2,000 15 Pred, HCQ 25.0
SLE17 F 38 192 21 8 Pred, HCQ, MMF 7.5
SLE18 F 47 114 1,400 14 Therapy naive 0
SLE19 F 59 26 0 5 Pred, Aza 5.0
SLE20 F 30 32 1,000 5 HCQ 0
SLE21 F 51 81 200 6 Pred, Aza 7.5
SLE22 F 28 56 0 6 Ciclosporine, Pred 5.0
SLE23 F 33 98 0 6 Pred, Aza 5.0
SLE24 F 32 155 17.5 18 Cylophosphamide, Pred 7.5
SLE25 F 29 19 positive 7 Ciclosporine, Pred -
SLE26 M 21 79 positive 6 Pred, MMF -
SLE27 F 37 118 positive 5 Pred, Aza -
SLE28 F 74 20 negative 5 Antimalarials -
SLE29 F 35 75 positive 6 Pred, Antimalarials -
SLE30 F 33 35 positive 7 Pred, MMF -
  1. Patient SLE18 was newly diagnosed and donated blood before immunosuppressive treatment was started. SLEDAI, systemic lupus erythematosus disease activity index; Pred, prednisolone; Aza, azathioprine; MTX, methotrexate; HCQ, hydroxychloroquine; MMF, mycophenolate mofetil; ND, not detected.